CBD is Everywhere – But Where Does the FDA Stand?
The Blunt Truth
AUGUST 13, 2019
The public hearing attracted over 100 speakers and 2000 participants. 331(ll)), the FDA prohibits the sale of products containing an ingredient that has been treated as a drug or involved in clinical trials, without prior FDA approval. Under section 331(ll) of the FD&C Act (21 U.S.C. First, Sens. 726) in March of 2019.
Let's personalize your content